BIOMAT Database Logo BIOMAT Database Logo

Synthesis and biological evaluation of celastrol derivatives as potent antitumor agents with STAT3 inhibition. 2022

Shaohua Xu, and Ruolan Fan, and Lu Wang, and Weishen He, and Haixia Ge, and Hailan Chen, and Wen Xu, and Jian Zhang, and Wei Xu, and Yaqian Feng, and Zhimin Fan
College of Pharmacy, Fujian University of Traditional Chinese Medicine, Fuzhou, P.R. China.

Using STAT3 inhibitors as a potential strategy in cancer therapy have attracted much attention. Recently, celastrol has been reported that it could directly bind to and suppress the activity of STAT3 in the cardiac dysfunction model. To explore more effective STAT3 inhibiting anti-tumour drug candidates, we synthesised a series of celastrol derivatives and biologically evaluated them with several human cancer cell lines. The western blotting analysis showed that compound 4 m, the most active derivative, could suppress the STAT3's phosphorylation as well as its downstream genes. SPR analysis, molecular docking and dynamics simulations' results indicated that the 4m could bind with STAT3 protein more tightly than celastrol. Then we found that the 4m could block cell-cycle and induce apoptosis on HCT-116 cells. Furthermore, the anti-tumour effect of 4m was verified on colorectal cancer organoid. This is the first research that discovered effective STAT3 inhibitors as potent anti-tumour agents from celastrol derivatives.

UI MeSH Term Description Entries
D008958 Models, Molecular Models used experimentally or theoretically to study molecular shape, electronic properties, or interactions; includes analogous molecules, computer-generated graphics, and mechanical structures. Molecular Models,Model, Molecular,Molecular Model
D002453 Cell Cycle The complex series of phenomena, occurring between the end of one CELL DIVISION and the end of the next, by which cellular material is duplicated and then divided between two daughter cells. The cell cycle includes INTERPHASE, which includes G0 PHASE; G1 PHASE; S PHASE; and G2 PHASE, and CELL DIVISION PHASE. Cell Division Cycle,Cell Cycles,Cell Division Cycles,Cycle, Cell,Cycle, Cell Division,Cycles, Cell,Cycles, Cell Division,Division Cycle, Cell,Division Cycles, Cell
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D004354 Drug Screening Assays, Antitumor Methods of investigating the effectiveness of anticancer cytotoxic drugs and biologic inhibitors. These include in vitro cell-kill models and cytostatic dye exclusion tests as well as in vivo measurement of tumor growth parameters in laboratory animals. Anticancer Drug Sensitivity Tests,Antitumor Drug Screens,Cancer Drug Tests,Drug Screening Tests, Tumor-Specific,Dye Exclusion Assays, Antitumor,Anti-Cancer Drug Screens,Antitumor Drug Screening Assays,Tumor-Specific Drug Screening Tests,Anti Cancer Drug Screens,Anti-Cancer Drug Screen,Antitumor Drug Screen,Cancer Drug Test,Drug Screen, Anti-Cancer,Drug Screen, Antitumor,Drug Screening Tests, Tumor Specific,Drug Screens, Anti-Cancer,Drug Screens, Antitumor,Drug Test, Cancer,Drug Tests, Cancer,Screen, Anti-Cancer Drug,Screen, Antitumor Drug,Screens, Anti-Cancer Drug,Screens, Antitumor Drug,Test, Cancer Drug,Tests, Cancer Drug,Tumor Specific Drug Screening Tests
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D014407 Tumor Cells, Cultured Cells grown in vitro from neoplastic tissue. If they can be established as a TUMOR CELL LINE, they can be propagated in cell culture indefinitely. Cultured Tumor Cells,Neoplastic Cells, Cultured,Cultured Neoplastic Cells,Cell, Cultured Neoplastic,Cell, Cultured Tumor,Cells, Cultured Neoplastic,Cells, Cultured Tumor,Cultured Neoplastic Cell,Cultured Tumor Cell,Neoplastic Cell, Cultured,Tumor Cell, Cultured
D015394 Molecular Structure The location of the atoms, groups or ions relative to one another in a molecule, as well as the number, type and location of covalent bonds. Structure, Molecular,Molecular Structures,Structures, Molecular
D017209 Apoptosis A regulated cell death mechanism characterized by distinctive morphologic changes in the nucleus and cytoplasm, including the endonucleolytic cleavage of genomic DNA, at regularly spaced, internucleosomal sites, i.e., DNA FRAGMENTATION. It is genetically programmed and serves as a balance to mitosis in regulating the size of animal tissues and in mediating pathologic processes associated with tumor growth. Apoptosis, Extrinsic Pathway,Apoptosis, Intrinsic Pathway,Caspase-Dependent Apoptosis,Classic Apoptosis,Classical Apoptosis,Programmed Cell Death,Programmed Cell Death, Type I,Apoptoses, Extrinsic Pathway,Apoptoses, Intrinsic Pathway,Apoptosis, Caspase-Dependent,Apoptosis, Classic,Apoptosis, Classical,Caspase Dependent Apoptosis,Cell Death, Programmed,Classic Apoptoses,Extrinsic Pathway Apoptoses,Extrinsic Pathway Apoptosis,Intrinsic Pathway Apoptoses,Intrinsic Pathway Apoptosis

Related Publications

Shaohua Xu, and Ruolan Fan, and Lu Wang, and Weishen He, and Haixia Ge, and Hailan Chen, and Wen Xu, and Jian Zhang, and Wei Xu, and Yaqian Feng, and Zhimin Fan
Design, synthesis and biological evaluation of novel plumbagin derivatives as potent antitumor agents with STAT3 inhibition.
November 2020, Bioorganic chemistry,
Shaohua Xu, and Ruolan Fan, and Lu Wang, and Weishen He, and Haixia Ge, and Hailan Chen, and Wen Xu, and Jian Zhang, and Wei Xu, and Yaqian Feng, and Zhimin Fan
Synthesis and biological evaluation of baicalein derivatives as potent antitumor agents.
March 2014, Bioorganic & medicinal chemistry letters,
Shaohua Xu, and Ruolan Fan, and Lu Wang, and Weishen He, and Haixia Ge, and Hailan Chen, and Wen Xu, and Jian Zhang, and Wei Xu, and Yaqian Feng, and Zhimin Fan
Synthesis and biological evaluation of benzothiazole derivatives as potent antitumor agents.
July 2005, Bioorganic & medicinal chemistry letters,
Shaohua Xu, and Ruolan Fan, and Lu Wang, and Weishen He, and Haixia Ge, and Hailan Chen, and Wen Xu, and Jian Zhang, and Wei Xu, and Yaqian Feng, and Zhimin Fan
Design, synthesis and biological evaluation of C6-modified celastrol derivatives as potential antitumor agents.
July 2014, Molecules (Basel, Switzerland),
Shaohua Xu, and Ruolan Fan, and Lu Wang, and Weishen He, and Haixia Ge, and Hailan Chen, and Wen Xu, and Jian Zhang, and Wei Xu, and Yaqian Feng, and Zhimin Fan
Synthesis and Biological Evaluation of Celastrol Derivatives as Potential Immunosuppressive Agents.
September 2020, Journal of natural products,
Shaohua Xu, and Ruolan Fan, and Lu Wang, and Weishen He, and Haixia Ge, and Hailan Chen, and Wen Xu, and Jian Zhang, and Wei Xu, and Yaqian Feng, and Zhimin Fan
Synthesis and biological evaluation of diarylthiazole derivatives as antimitotic and antivascular agents with potent antitumor activity.
July 2015, Bioorganic & medicinal chemistry,
Shaohua Xu, and Ruolan Fan, and Lu Wang, and Weishen He, and Haixia Ge, and Hailan Chen, and Wen Xu, and Jian Zhang, and Wei Xu, and Yaqian Feng, and Zhimin Fan
Synthesis and biological evaluation of N-(7-indolyl)-3-pyridinesulfonamide derivatives as potent antitumor agents.
August 2002, Bioorganic & medicinal chemistry letters,
Shaohua Xu, and Ruolan Fan, and Lu Wang, and Weishen He, and Haixia Ge, and Hailan Chen, and Wen Xu, and Jian Zhang, and Wei Xu, and Yaqian Feng, and Zhimin Fan
Synthesis and activity evaluation of phenylurea derivatives as potent antitumor agents.
June 2009, Bioorganic & medicinal chemistry,
Shaohua Xu, and Ruolan Fan, and Lu Wang, and Weishen He, and Haixia Ge, and Hailan Chen, and Wen Xu, and Jian Zhang, and Wei Xu, and Yaqian Feng, and Zhimin Fan
Synthesis and biological evaluation of cinnamyl compounds as potent antitumor agents.
October 2007, Bioorganic & medicinal chemistry letters,
Shaohua Xu, and Ruolan Fan, and Lu Wang, and Weishen He, and Haixia Ge, and Hailan Chen, and Wen Xu, and Jian Zhang, and Wei Xu, and Yaqian Feng, and Zhimin Fan
Synthesis and biological evaluation of dimeric cinnamaldehydes as potent antitumor agents.
April 2006, Bioorganic & medicinal chemistry,
Copied contents to your clipboard!